Please try another search
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company’s platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Shun’ichi Kuroda | - | 2004 | Co-Founder & Member of Scientific Advisory Board |
Don Robert Hankey | 80 | 2014 | Chairman of the Board |
Bruce W. Stroever | 73 | 2012 | Independent Director |
Siddhesh Rajendra Angle | 40 | 2021 | Independent Director |
Jeffrey C. Wang | - | 2005 | Member of Scientific Advisory Board |
Xinli Zhang | - | 2004 | Member of Scientific Advisory Board |
Robert E. Gagnon | 50 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review